0001209191-20-002077.txt : 20200106
0001209191-20-002077.hdr.sgml : 20200106
20200106180626
ACCESSION NUMBER: 0001209191-20-002077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAMSON MARVIN
CENTRAL INDEX KEY: 0000901056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 20511416
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001016169
ANTARES PHARMA, INC.
ATRS
0000901056
SAMSON MARVIN
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
0
0
0
Common Stock
2020-01-02
4
M
0
50000
2.18
A
101751
D
Common Stock
2020-01-02
4
S
0
50000
4.59
D
51751
D
Common Stock
2020-01-02
4
M
0
49395
2.18
A
101146
D
Common Stock
2020-01-02
4
S
0
49395
4.60
D
51751
D
Common Stock
2020-01-02
4
M
0
549
2.66
A
52300
D
Common Stock
2020-01-02
4
S
0
549
4.60
D
51751
D
Stock Option (right to buy)
2.18
2020-01-02
4
M
0
99395
0.00
D
2016-05-28
2025-05-27
Common Stock
99395
0
D
Stock Option (right to buy)
2.66
2020-01-02
4
M
0
549
0.00
D
2018-06-07
2027-06-06
Common Stock
549
0
D
The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning.
The options vested and became excercisable in four quarterly installments over the one-year period following the grant date of May 28, 2015.
The options vested and became exercisable in four quarterly installments over the one-year period following the grant date of June 7, 2017.
/s/Keith Muckenhirn as attorney-in-fact for Marvin Samson
2020-01-06